Therapeutic strategies for multi-resistant Escherichia coli in urinary tract infections—a cause for concern
Rekha Unni, Ruby Varghese, Benita Arakal, Lochana Padmanabhan, Srijita Karmakar, Achinthya Sampathila, Yogesh Bharat Dalvi, Paul Livingstone · 2026
Read Therapeutic strategies for multi-resistant Escherichia coli in urinary tract infections—a cause for concern by Rekha Unni, Ruby Varghese, Benita Arakal, Lochana Padmanabhan, Srijita Karmakar, Achinthya Sampathila, Yogesh Bharat Dalvi, Paul Livingstone (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13190274.txt.
Description
Rekha Unni and co-authors review treatment for drug resistant Escherichia coli in urinary tract infections, in a 2026 paper. More than eighty percent of such infections come from this germ, and many strains now resist several drug classes at once. Hard cases with other illnesses are the most worrying.
Most resistant strains make enzymes that break common drugs such as penicillins and their kin. Simple cases still have some options, but hard cases lean on a last line drug class whose own resistance is rising. Teams now pair drugs for joint effect and hunt for new agents, while other therapies with broad killing and immune effects gain interest.
Catalog record
| CREATOR | Rekha Unni, Ruby Varghese, Benita Arakal, Lochana Padmanabhan, Srijita Karmakar, Achinthya Sampathila, Yogesh Bharat Dalvi, Paul Livingstone |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 52 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |